2017;10. S4.3.5-36. Wald RM, Valente AM, Gauvreau K, et al. Cardiac magnetic res- onance markers of progressive RV dilation and dysfunction after tetralogy of Fallot repair. Heart. 2015;101:1724 30. S4.3.5-37. Bokma JP, Geva T, Sleeper LA, et al. A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Heart. 2017. S4.3.5-38. Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85 92. S4.3.5-39. Zubairi R, Malik S, Jaquiss RDB, et al. Risk factors for pros- thesis failure in pulmonary valve replacement. Ann Thorac Surg. 2011;91:561 5. S4.3.5-40. Cook SC, Valente AM, Maul TM, et al. Shock-related anxiety and sexual function in adults with congenital heart disease and implant- able cardioverter-defibrillators. Heart Rhythm. 2013;10:805 10. S4.3.5-41. Davlouros PA, Kilner PJ, Hornung TS, et al. Right ventricular func- tion in adults with repaired tetralogy of Fallot assessed with cardi- ovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol. 2002;40:2044 52. S4.3.5-42. Harrild DM, Berul CI, Cecchin F, et al. Pulmonary valve replace- ment in tetralogy of Fallot: impact on survival and ventricular tach- ycardia. Circulation. 2009;119:445 51. S4.3.5-43. Downar E, Harris L, Kimber S, et al. Ventricular tachycardia after surgical repair of tetralogy of Fallot: results of intraoperative map- ping studies. J Am Coll Cardiol. 1992;20:648 55. 4.3.6. Right Ventricle to-Pulmonary Artery Conduit S4.3.6-1. Morray BH, McElhinney DB, Cheatham JP, et al. Risk of coronary ar- tery compression among patients referred for transcatheter pulmo- nary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013;6:535 42. S4.3.6-2. Fraisse A, Assaidi A, Mauri L, et al. 